2.
Outcome | Gefitinib | Erlotinib | P |
PR:partical response; SD:stable disease; PD:progressive disease; DCR:disease control rate; RR:response rate. | |||
PR | 25 (51.0%) | 7 (41.2%) | |
SD | 20 (40.8%) | 8 (47.1%) | |
PD | 4 (8.2%) | 2 (11.7%) | |
DCR (%) | 91.1 | 86.7 | 0.643 |
RR (%) | 51.0 | 41.2 | 0.578 |